Abortifacient Agents - Administration & dosage
Research News and Information

Sunday, November 22, 2009

Mifepristone followed by high-dose oxytocin drip for second-trimester abortion: a randomized, double-blind, placebo-controlled, pilot study.

30 Jul 2009 OBJECTIVE: To study the effect of mifepristone for priming and induction of second-trimester abortion in conjunction with a high-concentration oxytocin drip. STUDY DESIGN: Prospective, randomized, placebo-controlled, pilot study. Thirty patients ... Read more...

Which approach for first trimester miscarriage?

29 Jun 2009 Around 15% of all known pregnancies miscarry during the first trimester. Historically, first trimester miscarriage was managed surgically to remove all retained products of conception, with the aim of minimising the likelihood of blood loss and ... Read more...

Choosing medical or surgical terminations of pregnancy in the first trimester: what is the difference?

30 Mar 2009 BACKGROUND: Women seeking termination of pregnancy in Auckland, New Zealand can chose between medical and surgical options up to eight weeks gestation. AIMS: To assess demographic differences or changes over time between proportions of women ... Read more...

Latest indexed articles for 'Abortifacient Agents - Administration & dosage'

These are the very latest articles for this heading:

• Mifepristone followed by high-dose oxytocin drip for second-trimester abortion: a randomized, double-blind, placebo-controlled, pilot study. 30 Jul 2009
• Which approach for first trimester miscarriage? 29 Jun 2009
• Choosing medical or surgical terminations of pregnancy in the first trimester: what is the difference? 30 Mar 2009
• Recent advances in second-trimester abortion: an evidence-based review. 30 Mar 2009
• Safety and efficacy of mid-term pregnancy termination using aglepristone in dogs. 27 Feb 2009
• Acute myocardial infarction following oral methyl-ergometrine intake. 12 Feb 2009
• Medication abortion as a quality indicator for regional comparisons in Sweden. 2 Dec 2008
• Is ovarian pregnancy a medical illness? Methotrexate treatment failure and rescue by laparoscopic removal. 29 Nov 2008
• Mifepristone and misoprostol versus Dilapan and sulprostone for second trimester termination of pregnancy. 30 Oct 2008
• First and second trimester induced abortions in women with cardiac disorders: a 12-year analysis from a developing country. 29 Sep 2008
• Medical management of early pregnancy failure: efficacy. 27 Sep 2008
• Antifertility potential of Neem flower extract on adult female Sprague-Dawley rats. 30 Aug 2008
• Miscarriage and ectopic pregnancy 2: management. 30 May 2008
• The choice of second trimester abortion method: evolution, evidence and ethics. 29 Apr 2008
• Misoprostol and pregnancy: risk of malformations. 30 Mar 2008
• [Safe illegal abortion would make an important contribution to decreasing maternal mortality and female suffering] 28 Feb 2008
• Intracardiac injection of potassium chloride as method for feticide: experience from a single UK tertiary centre. 28 Feb 2008
• Is misoprostol a safe, effective and acceptable alternative to manual vacuum aspiration for postabortion care? Results from a randomised trial in Burkina Faso, West Africa. 3 Sep 2007
• Repeated induction of abortion in bitches and the effect on plasma concentrations of relaxin, progesterone and estradiol-17beta. 25 Aug 2007
• Increasing access to safe abortion services in rural India: experiences with medical abortion in a primary health center. 23 May 2007

See a longer list of these articles.

Technical information about 'Abortifacient Agents'

Definition: Chemical substances that interrupt pregnancy after implantation.

Registry Number: 0

Descriptor UI: D000019

Alternative terms: Abortifacient Agents; Agents, Abortifacient; Abortifacients; Contraceptive Agents, Postconception; Agents, Postconception Contraceptive; Postconception Contraceptive Agents;

Related Mesh Headings: Oxytocics;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Tree Number: D27.505.696.875.131; D27.505.954.705.131;

History Note: 75

Technical Notes: do not use /ther use for use of abortifacients as abortifacients